Abstract

Eating behavior varies greatly between individuals, but the neurobiological basis of these trait-like differences in feeding remains poorly understood. Central μ-opioid receptors (MOR) and cannabinoid CB1 receptors (CB1R) regulate energy balance via multiple neural pathways, promoting food intake and reward. Because obesity and eating disorders have been associated with alterations in the brain’s opioid and endocannabinoid signaling, the variation in MOR and CB1R system function could potentially underlie distinct eating behavior phenotypes. In this retrospective positron emission tomography (PET) study, we analyzed [11C]carfentanil PET scans of MORs from 92 healthy subjects (70 males and 22 females), and [18F]FMPEP-d2 scans of CB1Rs from 35 subjects (all males, all also included in the [11C]carfentanil sample). Eating styles were measured with the Dutch Eating Behavior Questionnaire (DEBQ). We found that lower cerebral MOR availability was associated with increased external eating—individuals with low MORs reported being more likely to eat in response to environment’s palatable food cues. CB1R availability was associated with multiple eating behavior traits. We conclude that although MORs and CB1Rs overlap anatomically in brain regions regulating food reward, they have distinct roles in mediating individual feeding patterns. Central MOR system might provide a pharmacological target for reducing individual’s excessive cue-reactive eating behavior.

Details

Title
Cerebral μ-opioid and CB1 receptor systems have distinct roles in human feeding behavior
Author
Kantonen Tatu 1   VIAFID ORCID Logo  ; Karjalainen Tomi 2 ; Pekkarinen, Laura 3   VIAFID ORCID Logo  ; Isojärvi Janne 2 ; Kalliokoski Kari 2 ; Kaasinen Valtteri 4   VIAFID ORCID Logo  ; Hirvonen Jussi 5   VIAFID ORCID Logo  ; Nuutila Pirjo 3   VIAFID ORCID Logo  ; Nummenmaa Lauri 6   VIAFID ORCID Logo 

 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); University of Turku, Clinical Neurosciences, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371) 
 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481) 
 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); Turku University Hospital, Department of Endocrinology, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X) 
 University of Turku, Clinical Neurosciences, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371); Turku University Hospital, Neurocenter, Turku, Finland (GRID:grid.410552.7) (ISNI:0000 0004 0628 215X) 
 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); University of Turku and Turku University Hospital, Department of Radiology, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371) 
 Turku PET Centre, University of Turku, Turku, Finland (GRID:grid.470895.7) (ISNI:0000 0004 0391 4481); University of Turku, Department of Psychology, Turku, Finland (GRID:grid.1374.1) (ISNI:0000 0001 2097 1371) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
21583188
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2565277598
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.